RELAPSING FORMS OF MULTIPLE SCLEROSIS
Clinical trials for RELAPSING FORMS OF MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING FORMS OF MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING FORMS OF MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Real-World study shows ofatumumab cuts relapses in MS patients
Disease control CompletedThis study looked at how well and how safely ofatumumab (Kesimpta®) works for people with relapsing multiple sclerosis in Spain. Researchers followed 310 patients who had been on the drug for at least a year. The main goal was to see if the number of relapses (flare-ups of sympto…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 11:23 UTC
-
New MS drug combo shows promise in reducing brain lesions
Disease control CompletedThis study tested a new drug called BIIB091, taken alone or with an existing MS drug (diroximel fumarate), in 127 people with relapsing forms of multiple sclerosis. The goal was to check safety and see if the combination reduces new brain inflammation spots better than the existi…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated May 26, 2026 11:18 UTC
-
New MS drug shows promise in Asian-Pacific safety trial
Disease control CompletedThis study tested a drug called diroximel fumarate in 136 adults from East Asia with relapsing multiple sclerosis (MS). The goal was to see if the drug is safe and tolerable over 24 to 48 weeks. Researchers monitored side effects, lab results, and how the drug moves through the b…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 26, 2026 11:08 UTC